Senin, 14 Mei 2012

Tinnitus Key Cellular Mechanisms Identified

Tinnitus Key Cellular Mechanisms Identified

Editor's Choice
Main Category: Hearing / Deafness
Also Included In: Ear, Nose and Throat
Article Date: 14 May 2012 - 11:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions   <!-- rate icon rate article

Patient / Public:not yet rated

Healthcare Prof:not yet rated


About 10% of the population is affected by hearing loss and tinnitus, a perception of sounds, such as ringing or buzzing in the ear in the absence of corresponding external sound, which typically develops after acoustic over-exposure to loud noises. Scientists have speculated that tinnitus is caused by damaged nerve cells within the ear, but so far, there are no drugs available for the treatment or prevention of the condition.

The journal Hearing Research now reveals that researchers from the University of Leicester's Department of Cell Physiology and Pharmacology have discovered a cellular mechanism, which could be responsible for the development of tinnitus after exposure to loud noises. The finding could pave the way for the development of new drugs to treat tinnitus, and researchers are currently investigating potential drugs that could prevent the condition.

Research leader, Dr. Martine Hamann from Leicester University explained:

"We need to know the implications of acoustic over exposure, not only in terms of hearing loss but also what's happening in the brain and central nervous system. It's believed that tinnitus results from changes in excitability in cells in the brain - cells become more reactive, in this case more reactive to an unknown sound."

The researchers examined cells in the brain's dorsal cochlear nucleus area, which carries acoustic signals from the ear's nerve cells into the parts of the brain that decode and 'interpret' sounds. Exposure to loud noises affects some of the neurons in the dorsal cochlear nucleus to behave in an uncontrolled manner by starting to fire erratically, which ultimately leads to tinnitus.

Dr Hamann declared:

"We showed that exposure to loud sound triggers hearing loss a few days after the exposure to the sound. It also triggers this uncontrolled activity in the neurons of the dorsal cochlear nucleus. This is all happening very quickly, in a matter of days."

A major breakthrough was the team's discovery of the particular cellular mechanism that leads to the neurons' over-activity. They discovered that if potassium channels that help to control the nerve cell's electrical activity malfunction, the neurons are unable to return to a balanced resting state. These cells normally fire regularly and also regularly return to a resting state, yet if the potassium channels are malfunctioning, the cells are unable to return to a resting state and therefore continuously fire in random bursts, which creates the sensation of a constant noise even though there is no noise.

Dr Hamann explained:

"In normal conditions the channel helps to drag down the cellular electrical activity to its resting state and this allows the cell to function with a regular pattern. After exposure to loud sound, the channel is functioning less and therefore the cell is constantly active, being unable to reach its resting state and displaying those irregular bursts."

Even though numerous scientists have explored the dynamics of why tinnitus occurs, this is the first time that researchers have managed to characterize the cellular bursting activity in association with specific potassium channels. The ability to identify the potassium channels in the early stages of tinnitus paves the way for the development of new potential drug treatments to prevent the condition.

At present, Dr Hamann's team is exploring potential drugs that can control the damaged cells so that their erratic firing is blocked and they can revert to a resting state. The discovery of suitable drug components would mean that patients would be protected against the onset of tinnitus after experiencing acoustic overload. However, the development of a suitable drug to prevent tinnitus will take some years, given that investigations are still in their preliminary stage.

Leicester University, in collaboration with Autifony Therapeutics Ltd, will continue to conduct further pharmaceutical research via a Medical Research Council Case studentship, which is set to commence in October 2012.

Vivienne Michael, Chief Executive of Deafness Research UK, concluded:

"We're pleased to hear about this progress in such a debilitating hearing impairment. The charity continues to fund research into better treatments for tinnitus, with the ultimate aim of a cure. Our free information leaflets offer immediate help to sufferers and our national helpline provides additional support. Regularly tinnitus generates the most requests for help."

Written by Petra Rattue
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today

Please use one of the following formats to cite this article in your essay, paper or report:

MLA


APA

Please note: If no author information is provided, the source is cited instead.



Add Your Opinion On This Article

'Tinnitus Key Cellular Mechanisms Identified'

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



MediLexicon International Ltd Logo

Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Everyday Health Network back to top | home | privacy policy

MediLexicon International Ltd Logo MediLexicon International Ltd
Bexhill-on-Sea, United Kingdom
MediLexicon International Ltd © 2004-2012 All rights reserved.
MNT (logo) is the registered EU trade mark of MediLexicon Int. Limited.

Tidak ada komentar:

Posting Komentar